Levormeloxifene

{{Chembox | Verifiedfields = changed | verifiedrevid = 462091315 | ImageFile = Levormeloxifene.svg | ImageSize = 200px | IUPACName = 1-(2-{4-[(3R,4R)-7-methoxy-2,2-dimethyl-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenoxy}ethyl)pyrrolidine | OtherNames = | Section1 = ! colspan=2 style="background: #f8eaba; text-align: center;" |Identifiers

|-

|

CAS Number

|

• 31477-60-8 ^N

|-

|

3D model (JSmol)

|

• Interactive image

|-

| ChEMBL

|

• ChEMBL301327 ^Y

|- | ChemSpider

|

• 32935 ^Y

|-

|

PubChem CID

|

• 35805

|-

| UNII

|

• 9512UKZ352 ^Y

|-

|

CompTox Dashboard (EPA)

|

• DTXSID301317017 DTXSID6046844, DTXSID301317017

|-

| colspan="2" |

InChI

• InChI=1S/C30H35NO3/c1-30(2)29(23-9-5-4-6-10-23)28(26-16-15-25(32-3)21-27(26)34-30)22-11-13-24(14-12-22)33-20-19-31-17-7-8-18-31/h4-6,9-16,21,28-29H,7-8,17-20H2,1-3H3/t28-,29+/m1/s1 ^Y

  Key: XZEUAXYWNKYKPL-WDYNHAJCSA-N ^Y
• InChI=1/C30H35NO3/c1-30(2)29(23-9-5-4-6-10-23)28(26-16-15-25(32-3)21-27(26)34-30)22-11-13-24(14-12-22)33-20-19-31-17-7-8-18-31/h4-6,9-16,21,28-29H,7-8,17-20H2,1-3H3/t28-,29+/m1/s1

  Key: XZEUAXYWNKYKPL-WDYNHAJCBQ

|-

| colspan="2" |

SMILES

• O(c1ccc(cc1)[C@@H]3c4c(OC([C@H]3c2ccccc2)(C)C)cc(OC)cc4)CCN5CCCC5

|- | Section2 = ! colspan=2 style="background: #f8eaba; text-align: center;" |Properties

|-

|

Chemical formula

| C₃₀H₃₅NO₃

|- | Molar mass

| 457.604

|- | Section3 = }}

Levormeloxifene is an experimental selective estrogen receptor modulator that was being developed as an alternative to estrogen replacement therapy for the treatment and prevention of postmenopausal bone loss. The development was stopped because of a high incidence of gynaecologic adverse events during clinical trials. It is the enantiomer of ormeloxifene.